London Stock Exchange
3 November 2000
For the attention of the
chairman/senior partner/compliance officer,
all member firms N60/00
STOCK EXCHANGE NOTICE
DOMESTIC EQUITY MARKET
SYNGENTA AG ('SYNGENTA')
1. Listing particulars have been filed in relation to the global secondary
offering of ordinary shares in Syngenta. Syngenta will be formed through the
combination of the de-merged agrochemicals business of AstraZeneca plc and the
agribusiness of Novartis AG. Subject to approval by the UK Listing Authority,
Syngenta will obtain a secondary listing in London and will be admitted to
trading on the London Stock Exchange on 13 November 2000.
2. As a Swiss incorporated company with a primary listing in Zurich, Syngenta
would normally be classified as a European equity market security and be
quoted on SEAQ International. However, given the expectation of high trading
volumes in London during the period immediately following admission, including
the anticipated level of UK retail participation, the Exchange has agreed
that, on an exceptional basis, Syngenta will be treated as a domestic equity
market security and will be traded on SEAQ with effect from 13 November 2000.
This will ensure the appropriate level of visibility and accessibility for
those member firms wishing to trade this security on the London Stock
Exchange. The Exchange will review the ongoing suitability of the quotation
on SEAQ after the initial period of trading.
3. In light of its treatment as a domestic equity market security, all trading
and reporting obligations, as set out within chapters 4 and 8 of the Rules of
the London Stock Exchange, will apply.
Andrew McStravick
Head of Market Operations
Any queries relating to the admission of Syngenta to SEAQ should be addressed
to Marcus Stuttard, Company Services, telephone 020 7797 3364 (STX 33364) or
email mstuttard@londonstockexchange.com.
Any queries relating to the application of the Exchange's rules should be
addressed to Mathew Wootton, Regulatory Development, telephone 020 7797 1570
(STX 31570) or email mwootton@londonstockexchange.com.
This Stock Exchange Notice will be available on the website at
www.londonstockexchange.com/regulation/notices/
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.